Decode Health and Circular Genomics will use AI to identify patterns in circular RNA in blood that may help diagnose and ...

Using circular RNA, we’ve developed a platform we call isCAR™ for the in vivo delivery of CARs to immune cells. RNA is transient, but circular RNA, compared to linear mRNA, persists much longer in ...

TI-0032 first-in-human study initiated; US/China dual IND filing on trackBEIJING & SHANGHAI--(BUSINESS ...

This webinar will highlight how circular RNA overcomes key challenges in in vivo CAR-T therapy, with case examples from YXgene’s circRNA platform. In vivo CAR-T therapy is emerging as a transformative ...

For decades, circular RNA was treated as little more than molecular background noise — stable fragments that accumulated in ...

The recognition of mRNA molecules as a transformative class of therapeutic drugs has soared, particularly with the development of COVID 19 mRNA vaccines. The cancer treatment landscape is similarly ...

When researchers first observed the presence of circular RNAs in the 1970s, they were an inexplicable biological oddity — and they remained so for many years afterward. The field of RNA biology was in ...

A study identifies a novel self-replicating circular RNA in hot springs, revealing unexpected diversity of RNA replicators, ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

The use of RNA is a promising approach for a growing range of therapeutics and vaccines, but overcoming a few challenges would enable it even further. Stability and persistence in the body are ...